Nursing care
Why chronic kidney disease causes bone disease: phosphate, vitamin D and PTH
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated October 2026
Short answer
Failing kidneys cannot excrete phosphate or activate vitamin D. Phosphate builds up, calcium absorption falls, and the parathyroid glands respond by releasing more parathyroid hormone, which pulls calcium out of bone. Over time bones weaken and vessels can calcify. Phosphate binders with meals, a lower-phosphorus diet and vitamin D therapy target each step.
What healthy kidneys do for bones
Healthy kidneys keep minerals in balance in two ways. They excrete excess phosphate in the urine, and they convert vitamin D into its active form, calcitriol. Calcitriol helps the gut absorb calcium from food. Parathyroid hormone, or PTH, from the parathyroid glands fine-tunes the system by acting on bone, kidney and, indirectly, the gut.
As chronic kidney disease progresses, both kidney functions decline together. This combination is now called CKD mineral and bone disorder, which covers abnormal laboratory values, bone changes and calcification of blood vessels. The older term renal osteodystrophy describes the bone part. The problem develops gradually, so laboratory trends often change long before the client has symptoms.
The chain from phosphate to hyperparathyroidism
First, phosphate is retained because the kidneys cannot excrete it, producing hyperphosphataemia. Second, less calcitriol is made, so less calcium is absorbed from food and blood calcium tends to fall. Phosphate also binds calcium in the blood, lowering it further. The parathyroid glands sense these changes and increase PTH production, a response called secondary hyperparathyroidism.
PTH raises blood calcium partly by releasing calcium from bone. In healthy kidneys PTH would also boost phosphate excretion, but damaged kidneys cannot respond well, so the cycle continues. Over months and years the parathyroid glands enlarge and bone turnover becomes abnormal. Bone can become weak, painful and prone to fracture, and in children growth may be affected.
Why the same process harms blood vessels
High phosphate, particularly combined with calcium, encourages mineral deposits in blood vessels and soft tissues. This vascular calcification stiffens arteries and adds to the already high cardiovascular risk in kidney disease. It means mineral control in CKD protects the heart as well as the skeleton, which is useful context when clients ask why diet rules matter so much.
Treatment can overshoot. Suppressing PTH too far, for example with excessive vitamin D analogues or calcium, can produce low-turnover bone disease, in which bone becomes inactive and still fragile. This is why the team aims for balanced targets rather than the lowest possible PTH, and why the nurse reports rising calcium as readily as rising phosphate.
Turning the mechanism into nursing care
Phosphate binders work in the gut by attaching to phosphate in food so it is passed in stool rather than absorbed. They therefore need to be taken with meals and snacks as prescribed, not on an empty stomach. Teach clients to limit high-phosphorus foods, including processed foods and colas, and to look for ingredients containing the letters phos on labels.
Other treatments target later steps: active vitamin D replaces missing calcitriol, calcimimetics lower PTH, dialysis removes some phosphate, and parathyroidectomy may be considered when PTH stays very high. Monitor calcium, phosphate and PTH trends, report symptoms such as bone pain, itching or muscle cramps, and involve a renal dietitian to make the diet practical.
Reason through a hypothetical scenario
A hypothetical client on haemodialysis has rising phosphate and PTH. The client takes a calcium acetate binder each morning before breakfast and eats processed meats most days. Options include increasing dairy intake to raise calcium, moving the binder to bedtime, teaching the client to take the binder with each meal and review phosphorus foods, or giving an extra dose of active vitamin D.
Teaching about binder timing and diet is correct because binders only work when food phosphate is present in the gut. Extra dairy adds phosphate. Bedtime dosing misses meals entirely. Changing vitamin D therapy is a prescriber decision and does not fix the root problem of phosphate absorption. The mechanism makes the nursing teaching point clear.
Sources and further reading
NIDDK: Mineral and bone disorder in chronic kidney disease. Phosphorus build-up, reduced calcitriol, PTH moving calcium from bone, weak bones, vessel calcification, phos label advice, binders, calcitriol, calcimimetics, dialysis and parathyroidectomy.
MSD Manual Professional: Chronic kidney disease. Phosphate retention, low calcitriol and hypocalcaemia, secondary hyperparathyroidism, high and low turnover bone disease, binder choices and avoiding PTH over-suppression.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our renal and genitourinary practice questions are the closest set to what this page covers.
Common questions
Why does PTH rise in chronic kidney disease?
Retained phosphate, low active vitamin D and falling calcium all stimulate the parathyroid glands. The resulting secondary hyperparathyroidism draws calcium out of bone and weakens it.
Why must phosphate binders be taken with food?
They bind phosphate in the meal while it is in the gut. Taken without food, they have little phosphate to bind and do not lower blood levels effectively.
Is high calcium a good sign in CKD bone disease?
Not necessarily. Excess calcium can contribute to vessel calcification, and over-suppressing PTH can cause low-turnover bone disease. Report high and low values alike.